A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy

Abstract Background Patients with hepatocellular carcinoma (HCC) undergoing surgical resection still have a high 5-year recurrence rate (~ 60%). With the development of laparoscopic hepatectomy (LH), few studies have compared the efficacy between LH and traditional surgical approach on HCC. The obje...

Full description

Bibliographic Details
Main Authors: Yang-Xun Pan, Jian-Cong Chen, Ai-Ping Fang, Xiao-Hui Wang, Jin-Bin Chen, Jun-Cheng Wang, Wei He, Yi-Zhen Fu, Li Xu, Min-Shan Chen, Yao-Jun Zhang, Qi-Jiong Li, Zhong-Guo Zhou
Format: Article
Language:English
Published: Wiley 2019-10-01
Series:Cancer Communications
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40880-019-0404-6
_version_ 1818998412869107712
author Yang-Xun Pan
Jian-Cong Chen
Ai-Ping Fang
Xiao-Hui Wang
Jin-Bin Chen
Jun-Cheng Wang
Wei He
Yi-Zhen Fu
Li Xu
Min-Shan Chen
Yao-Jun Zhang
Qi-Jiong Li
Zhong-Guo Zhou
author_facet Yang-Xun Pan
Jian-Cong Chen
Ai-Ping Fang
Xiao-Hui Wang
Jin-Bin Chen
Jun-Cheng Wang
Wei He
Yi-Zhen Fu
Li Xu
Min-Shan Chen
Yao-Jun Zhang
Qi-Jiong Li
Zhong-Guo Zhou
author_sort Yang-Xun Pan
collection DOAJ
description Abstract Background Patients with hepatocellular carcinoma (HCC) undergoing surgical resection still have a high 5-year recurrence rate (~ 60%). With the development of laparoscopic hepatectomy (LH), few studies have compared the efficacy between LH and traditional surgical approach on HCC. The objective of this study was to establish a nomogram to evaluate the risk of recurrence in HCC patients who underwent LH. Methods The clinical data of 432 patients, pathologically diagnosed with HCC, underwent LH as initial treatment and had surgical margin > 1 cm were collected. The significance of their clinicopathological features to recurrence-free survival (RFS) was assessed, based on which a nomogram was constructed using a training cohort (n = 324) and was internally validated using a temporal validation cohort (n = 108). Results Hepatitis B surface antigen (hazard ratio [HR], 1.838; P = 0.044), tumor number (HR, 1.774; P = 0.003), tumor thrombus (HR, 2.356; P = 0.003), cancer cell differentiation (HR, 0.745; P = 0.080), and microvascular tumor invasion (HR, 1.673; P  =0.007) were found to be independent risk factors for RFS in the training cohort, and were used for constructing the nomogram. The C-index for RFS prediction in the training cohort using the nomogram was 0.786, which was higher than that of the 8th edition of the American Joint Committee on Cancer TNM classification (C-index, 0.698) and the Barcelona Clinic Liver Cancer staging system (C-index, 0.632). A high consistency between the nomogram prediction and actual observation was also demonstrated by a calibration curve. An improved predictive benefit in RFS and higher threshold probability of the nomogram were determined by receiver operating characteristic curve analysis, which was also confirmed in the validation cohort compared to other systems. Conclusions We constructed and validated a nomogram able to quantify the risk of recurrence after initial LH for HCC patients, which can be clinically implemented in assisting the planification of individual postoperative surveillance protocols.
first_indexed 2024-12-20T22:01:07Z
format Article
id doaj.art-304738053b46447aa26ca4cd09e3e25e
institution Directory Open Access Journal
issn 2523-3548
language English
last_indexed 2024-12-20T22:01:07Z
publishDate 2019-10-01
publisher Wiley
record_format Article
series Cancer Communications
spelling doaj.art-304738053b46447aa26ca4cd09e3e25e2022-12-21T19:25:21ZengWileyCancer Communications2523-35482019-10-0139111110.1186/s40880-019-0404-6A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomyYang-Xun Pan0Jian-Cong Chen1Ai-Ping Fang2Xiao-Hui Wang3Jin-Bin Chen4Jun-Cheng Wang5Wei He6Yi-Zhen Fu7Li Xu8Min-Shan Chen9Yao-Jun Zhang10Qi-Jiong Li11Zhong-Guo Zhou12State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Public Health, Sun Yat-sen UniversityState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterAbstract Background Patients with hepatocellular carcinoma (HCC) undergoing surgical resection still have a high 5-year recurrence rate (~ 60%). With the development of laparoscopic hepatectomy (LH), few studies have compared the efficacy between LH and traditional surgical approach on HCC. The objective of this study was to establish a nomogram to evaluate the risk of recurrence in HCC patients who underwent LH. Methods The clinical data of 432 patients, pathologically diagnosed with HCC, underwent LH as initial treatment and had surgical margin > 1 cm were collected. The significance of their clinicopathological features to recurrence-free survival (RFS) was assessed, based on which a nomogram was constructed using a training cohort (n = 324) and was internally validated using a temporal validation cohort (n = 108). Results Hepatitis B surface antigen (hazard ratio [HR], 1.838; P = 0.044), tumor number (HR, 1.774; P = 0.003), tumor thrombus (HR, 2.356; P = 0.003), cancer cell differentiation (HR, 0.745; P = 0.080), and microvascular tumor invasion (HR, 1.673; P  =0.007) were found to be independent risk factors for RFS in the training cohort, and were used for constructing the nomogram. The C-index for RFS prediction in the training cohort using the nomogram was 0.786, which was higher than that of the 8th edition of the American Joint Committee on Cancer TNM classification (C-index, 0.698) and the Barcelona Clinic Liver Cancer staging system (C-index, 0.632). A high consistency between the nomogram prediction and actual observation was also demonstrated by a calibration curve. An improved predictive benefit in RFS and higher threshold probability of the nomogram were determined by receiver operating characteristic curve analysis, which was also confirmed in the validation cohort compared to other systems. Conclusions We constructed and validated a nomogram able to quantify the risk of recurrence after initial LH for HCC patients, which can be clinically implemented in assisting the planification of individual postoperative surveillance protocols.http://link.springer.com/article/10.1186/s40880-019-0404-6Hepatocellular carcinomaLaparoscopic hepatectomyRecurrenceNomogramAmerican Joint Committee on Cancer TNM classificationBarcelona Clinic Liver Cancer staging system
spellingShingle Yang-Xun Pan
Jian-Cong Chen
Ai-Ping Fang
Xiao-Hui Wang
Jin-Bin Chen
Jun-Cheng Wang
Wei He
Yi-Zhen Fu
Li Xu
Min-Shan Chen
Yao-Jun Zhang
Qi-Jiong Li
Zhong-Guo Zhou
A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
Cancer Communications
Hepatocellular carcinoma
Laparoscopic hepatectomy
Recurrence
Nomogram
American Joint Committee on Cancer TNM classification
Barcelona Clinic Liver Cancer staging system
title A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
title_full A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
title_fullStr A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
title_full_unstemmed A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
title_short A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
title_sort nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
topic Hepatocellular carcinoma
Laparoscopic hepatectomy
Recurrence
Nomogram
American Joint Committee on Cancer TNM classification
Barcelona Clinic Liver Cancer staging system
url http://link.springer.com/article/10.1186/s40880-019-0404-6
work_keys_str_mv AT yangxunpan anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT jiancongchen anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT aipingfang anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT xiaohuiwang anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT jinbinchen anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT junchengwang anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT weihe anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT yizhenfu anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT lixu anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT minshanchen anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT yaojunzhang anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT qijiongli anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT zhongguozhou anomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT yangxunpan nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT jiancongchen nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT aipingfang nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT xiaohuiwang nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT jinbinchen nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT junchengwang nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT weihe nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT yizhenfu nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT lixu nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT minshanchen nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT yaojunzhang nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT qijiongli nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy
AT zhongguozhou nomogrampredictingtherecurrenceofhepatocellularcarcinomainpatientsafterlaparoscopichepatectomy